Wilko Single Dose Wormer for Dogs and Puppies, 500 mg Film Coated Tablets

Riik: Suurbritannia

keel: inglise

Allikas: VMD (Veterinary Medicines Directorate)

Toimeaine:

Nitroscanate

Saadav alates:

Novartis Animal Health UK Ltd

ATC kood:

QP52AX01

INN (Rahvusvaheline Nimetus):

Nitroscanate

Volitamisolek:

Expired

Toote omadused

Revised: 04 June 2008
AN: 01779/2007
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Wilko Single Dose Wormer for Dogs and Puppies, 500mg film coated
tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/tablet
Nitroscanate
500
For a full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablets.
Yellowish-white to light beige round, film coated tablet.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs over 8 weeks old.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Wilko Single Dose Wormer for Dogs and Puppies is a broad spectrum
anthelmintic
for use in dogs from 8 weeks of age. It is highly effective in a
single dose against
common canine nematodes and cestodes in the UK, including _Toxocara
canis, _
_Toxascaris leonina, Ancylostoma caninum, Uncinaria stenocephala,
Taenia ovis, _
_Taenia hydatigena, Taenia pisiformis _and_ Dipylidium caninum._
At the recommended dosage, the product gives limited control of
_Echinococcus _
_granulosus._
4.3
CONTRAINDICATIONS
Do not administer if your dog is sick or recovering from an illness.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: 04 June 2008
AN: 01779/2007
4.5
SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not repeat treatment if vomiting occurs shortly after dosing.
II)
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
MEDICINAL
PRODUCT TO ANIMALS
Tablets are film coated and should not be broken or divided.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
The tablets, when administered as recommended are unlikely to cause
vomiting. (See
section 4.5 i).
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated in pregnant animals. Nursing females should be
treated at the
same time and as frequently as puppies up to 12 weeks of age.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNT(S) TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For the routine treatment of dogs and puppies weighing more